查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1462642

2030 年胍丁胺市场预测：按形式、销售管道、应用和地区进行的全球分析

Agmatine Market Forecasts to 2030 - Global Analysis By Form, Sales Channel, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC的数据，2023年全球胍丁胺市场规模为5,970万美元，预计2030年将达到1.216亿美元，预测期内复合年增长率为10.7%。

胍丁胺市场是指硫酸胍丁胺的全球贸易和消费量，硫酸胍丁胺是一种源自氨基酸精氨酸的化合物。胍丁胺因其潜在的健康益处而受到关注，包括提高运动表现、控制疼痛和支持认知功能。由于它有望具有神经保护作用，因此被视为治疗神经病变疼痛和忧郁症神经系统疾病的有前途的药物。

根据世界卫生组织（WHO）统计，慢性病占全球整体死亡人数的74%，每年约造成4,100万人死亡，其中约1,700万人在70岁前死亡。

运动和健身活动的受欢迎程度

体育和健身活动的流行是胍丁胺市场的驱动因素，因为人们认为胍丁胺在提高运动表现和恢復方面具有好处。运动员和健身爱好者不断寻找优化训练方案和提高身体表现的方法，导致对胍丁胺等补充品的需求增加。胍丁胺对这一人群特别有吸引力，因为它据称能够增加一氧化氮的产生、改善血流量、增强耐力和肌肉泵。此外，随着人们越来越注重实现健身目标和维持整体健康，将营养补充食品日常生活的趋势日益明显，进一步推动了对胍丁胺产品的需求。

价格敏感度

与其他营养补充相比，胍丁胺的售价通常较高，这可能会阻止对价格敏感的消费者定期购买它。这种定价动态可能会限制市场的成长潜力，特别是对于在医疗保健支出中优先考虑成本效益的消费者而言。胍丁胺产品可能难以在市场上普及接受，因为市场上可以以较低的价格获得类似有效的替代品。然而，胍丁胺市场的製造商和负责人面临着平衡产品品质和功效与承受能力的挑战，以吸引更广泛的消费者群体。

重视预防保健

随着人们越来越认识到保持最佳健康对于预防疾病和促进长寿的重要性，人们对胍丁胺等补充品的兴趣似乎与日俱增，其健康益处似乎超出了基本营养摄入。胍丁胺的神经保护特性及其在维持心血管健康、疼痛管理和认知增强方面的作用，与预防保健的目标一致。在寻找改善整体健康和降低慢性病风险的方法时，营养补充食品成为医疗保健的补充方法。

有限的临床证据

儘管初步研究表明其具有潜在的健康益处，例如神经保护、疼痛管理和认知增强，但缺乏强有力的临床试验或全面研究表明其有效性可能不确定，其安全性和有效性仍存在不确定性。如果没有足够的科学检验，消费者、医疗保健专业人员和监管机构可能在推荐或核准胍丁胺产品时保持谨慎态度，这可能会限制市场成长。然而，缺乏确凿的证据可能会让潜在消费者持怀疑态度，并阻止他们投资胍丁胺补充品。

COVID-19 的影响：

随着消费者健康意识的增强并专注于增强免疫力，对食品胍丁胺的营养补充的需求正在迅速增加。这一趋势是由对维持整体健康和抵御病毒的能力的担忧所推动的。疫情也扰乱了全球供应链和製造运营，为原材料采购和最终产品製造带来了挑战。然而，经济的不确定性和消费者支出模式的变化正在影响购买行为，有些人优先考虑必需品而不是营养补充等可自由支配的购买。

预计粉末细分市场在预测期内将是最大的

由于其便利性和多功能性，粉末细分市场预计将在预测期内占据最大的市场份额，使消费者可以轻鬆地将其混合到饮料中或将其纳入食谱中，以满足不同的偏好和生活方式。这种易用性增加了胍丁胺产品的吸引力，特别是对于寻求一种简单且可自订的方式将营养补充食品日常生活的个人而言。此外，粉末配方通常比其他型态含有更高浓度的胍丁胺，使其更具成本绩效，并可能吸引註重成本的消费者。

预计药局产业在预测期内复合年增长率最高。

预计药局业务在整个管制期间将保持盈利成长。胍丁胺将越来越受到寻求天然替代品的消费者的追捧，因为该细分市场因其潜在的健康益处（包括缓解疼痛、增强情绪和改善认知功能）而获得认可。药局利用其广泛的影响力和消费者的信任，积极库存和促销胍丁胺产品，从而推动需求。

比例最高的地区：

良好的监管标准、对食品营养补充和营养成分法的修订以促进其使用和消费，以及更加重视探索神经保护和改善情绪特性的产品的潜力，预计将导致亚太地区在预测期内实现增长。最大的市场占有率。在这些特性不断增加的地区，对含有胍丁胺的产品的需求可能会受到 GDP 成长率、可支配收入水准和消费者购买模式等经济因素的影响。

复合年增长率最高的地区：

预计亚太地区在预测期内将出现良好的成长。监管机构越来越认识到胍丁胺在药品、营养补充和农业中的安全性和有效性，增加了製造商和消费者的信心。简化的核准流程和明确的胍丁胺使用指南使得将胍丁胺纳入产品中变得更加容易，从而推动了该地区的市场成长。此外，旨在促进该地区研究和创新的支持政策鼓励了对胍丁胺相关研发活动的投资，从而促进了新应用和生产方法的开发。

提供免费客製化：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次研究资料
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球胍丁胺市场：依形状分类

  • 胶囊
  • 粉末

第六章全球胍丁胺市场：依销售管道分类

  • 专卖店
  • 药局
  • 保健/美容店
  • 第三方线上通路
  • 其他销售管道

第七章全球胍丁胺市场：依应用分类

  • 补充品和营养补充食品
  • 製药
  • 其他用途

第八章全球胍丁胺市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司概况

  • Ajinomoto Co., Inc
  • Douglas Laboratories
  • Dymatize Nutrition
  • Glanbia Nutritionals
  • Jarrow Formulas
  • Metabolic Maintenance
  • NOW Foods Inc
  • Nutrabio Inc
  • Prinova Group LLC
  • Swanson Health
Product Code: SMRC25693

According to Stratistics MRC, the Global Agmatine Market is accounted for $59.7 million in 2023 and is expected to reach $121.6 million by 2030 growing at a CAGR of 10.7% during the forecast period. The agmatine market refers to the global trade and consumption of agmatine sulfate, a compound derived from the amino acid arginine. Agmatine has gained attention for its potential health benefits, including its role in enhancing athletic performance, managing pain, and supporting cognitive function. It is utilized for its potential neuroprotective properties, making it a promising candidate for the treatment of neurological disorders like neuropathic pain and depression.

According to the World Health Organization, chronic diseases are the major cause of death globally with around 41 million deaths each year equivalent to 74% of total deaths globally, and around 17 million out of these deaths take place before age 70.

Market Dynamics:

Driver:

Popularity of sports and fitness activities

The popularity of sports and fitness activities serves as a driver of the agmatine market due to the compound's perceived benefits in enhancing athletic performance and recovery. Athletes and fitness enthusiasts are continually seeking ways to optimize their training regimens and improve their physical capabilities, leading to a growing demand for supplements like agmatine. Agmatine's purported ability to increase nitric oxide production, improve blood flow, and enhance endurance and muscle pump makes it particularly attractive to this demographic. Moreover, as individuals become increasingly focused on achieving their fitness goals and maintaining overall well-being, they are more inclined to incorporate nutritional supplements into their routines, further propelling the demand for agmatine products.

Restraint:

Price sensitivity

Agmatine often come at a premium price compared to other nutritional products, which can deter price-conscious consumers from purchasing them regularly. This pricing dynamic may limit the market's growth potential, especially among individuals who prioritize cost-effectiveness in their healthcare spending. In markets where alternatives offering similar benefits are available at lower prices, agmatine products may struggle to gain traction. However, manufacturers and marketers in the agmatine market face the challenge of balancing product quality and efficacy with affordability to appeal to a broader consumer base.

Opportunity:

Focus on preventive healthcare

With rising awareness of the importance of maintaining optimal health to prevent diseases and promote longevity, there's a growing interest in supplements like agmatine that offer potential health benefits beyond basic nutrition. Agmatine's purported neuroprotective properties, along with its role in supporting cardiovascular health, managing pain, and enhancing cognitive function, align well with the goals of preventive healthcare. As individuals seek ways to enhance their overall well-being and reduce the risk of chronic conditions, they are turning to dietary supplements as a complementary approach to their healthcare regimen.

Threat:

Limited clinical evidence

While preliminary research suggests potential health benefits, including neuroprotection, pain management, and cognitive enhancement, the lack of robust clinical trials and comprehensive studies leaves uncertainties regarding its efficacy and safety. Without sufficient scientific validation, consumers, healthcare professionals, and regulatory bodies may remain cautious about recommending or approving agmatine products, limiting market growth. However, the absence of conclusive evidence may lead to skepticism among potential consumers, deterring them from investing in agmatine supplements.

Covid-19 Impact:

There has been a surge in demand for dietary supplements, including agmatine, as consumers have become increasingly health-conscious and focused on boosting their immunity. This trend has been driven by concerns about maintaining overall wellness and resilience against the virus. The pandemic has also disrupted global supply chains and manufacturing operations, leading to challenges in sourcing raw materials and producing finished products. However, economic uncertainties and changes in consumer spending patterns have influenced purchasing behaviors, with some individuals prioritizing essential goods over discretionary purchases like dietary supplements.

The powder segment is expected to be the largest during the forecast period

Powder segment is prophesied to witness the largest share of the market during the overcast period as it offers convenience and versatility, allowing consumers to easily mix them into beverages or incorporate them into recipes, catering to diverse preferences and lifestyles. This ease of use enhances the appeal of agmatine products, particularly among individuals seeking simple and customizable ways to integrate nutritional supplements into their daily routines. Additionally, powdered formulations often provide higher concentrations of agmatine per serving compared to other formats, offering better value for money and potentially attracting cost-conscious consumers.

The drug stores segment is expected to have the highest CAGR during the forecast period

Drug Stores segment is positioned to hold profitable growth throughout the domination period. As agmatine gains recognition in this segment for its potential health benefits, such as pain relief, mood enhancement, and cognitive improvement, it becomes increasingly sought after by consumers looking for natural alternatives. Drug stores, leveraging their widespread presence and consumer trust, actively stock and promote agmatine products, thereby driving demand.

Region with largest share:

Due to favorable regulatory standards, changes in laws pertaining to dietary supplements and nutritional ingredients that promote their use and consumption, and a growing emphasis on examining the product's potential for neuroprotective and mood-enhancing properties, the Asia-Pacific region is anticipated to hold the largest share during the projection period. The demand for products containing agmatine in the region where these characteristics are increasing can be influenced by economic factors such as GDP growth, levels of disposable income, and consumer purchasing patterns.

Region with highest CAGR:

Asia Pacific is expected to witness lucrative growth over the extrapolated period. Regulatory bodies are increasingly acknowledging the safety and efficacy of agmatine in pharmaceuticals, dietary supplements, and agriculture, which is instilling confidence among manufacturers and consumers alike. Streamlined approval processes and clear guidelines regarding the use of agmatine are facilitating its incorporation into products, thereby driving market growth in the region. Additionally, supportive policies aimed at promoting research and innovation in the region is encouraging investment in R&D activities related to agmatine, leading to the development of new applications and production methods.

Key players in the market

Some of the key players in Agmatine market include Ajinomoto Co., Inc, Douglas Laboratories, Dymatize Nutrition, Glanbia Nutritionals, Jarrow Formulas, Metabolic Maintenance, NOW Foods Inc, Nutrabio Inc, Prinova Group LLC and Swanson Health.

Key Developments:

In August 2023, Hi-Tech Pharmaceuticals, unveiled its new KRANK3D pre-workout supplement, that utilizes the novel approach called Arginase Inhibition. It is mainly designed to accelerate muscle growth through creating a feeding pool flourishing with compounds.

In April 2023, Bucked Up, a leading sports nutrition and lifestyle brand, announced the launch of a first-of-its-kind pre-workout product called Pixie Pump. The newly developed product includes agmatine, nitrosigine, Vitamin B6, Vitamin B12, and Himalayan rock salt, and is free from caffeine.

In January 2022, Dr. Riggs Rhelief, introduced its new revolutionary functional herbal beverage powder, which offers significant pain relief within just a few minutes and is also quickly absorbed into the bloodstream. The newly launched beverage contains the amino acid arginine, which is metabolized into agmatine and ornithine, resulting in less nerve pain.

Forms Covered:

  • Capsules
  • Powder

Sales Channels Covered:

  • Specialty Stores
  • Drug Stores
  • Health & Beauty Stores
  • Third-party Online Channels
  • Other Sales Channels

Applications Covered:

  • Supplements & Nutraceuticals
  • Pharmaceutical
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Agmatine Market, By Form

  • 5.1 Introduction
  • 5.2 Capsules
  • 5.3 Powder

6 Global Agmatine Market, By Sales Channel

  • 6.1 Introduction
  • 6.2 Specialty Stores
  • 6.3 Drug Stores
  • 6.4 Health & Beauty Stores
  • 6.5 Third-party Online Channels
  • 6.6 Other Sales Channels

7 Global Agmatine Market, By Application

  • 7.1 Introduction
  • 7.2 Supplements & Neutraceuticals
  • 7.3 Pharmaceutical
  • 7.4 Other Applications

8 Global Agmatine Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Ajinomoto Co., Inc
  • 10.2 Douglas Laboratories
  • 10.3 Dymatize Nutrition
  • 10.4 Glanbia Nutritionals
  • 10.5 Jarrow Formulas
  • 10.6 Metabolic Maintenance
  • 10.7 NOW Foods Inc
  • 10.8 Nutrabio Inc
  • 10.9 Prinova Group LLC
  • 10.10 Swanson Health

List of Tables

  • Table 1 Global Agmatine Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Agmatine Market Outlook, By Form (2021-2030) ($MN)
  • Table 3 Global Agmatine Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 4 Global Agmatine Market Outlook, By Powder (2021-2030) ($MN)
  • Table 5 Global Agmatine Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 6 Global Agmatine Market Outlook, By Specialty Stores (2021-2030) ($MN)
  • Table 7 Global Agmatine Market Outlook, By Drug Stores (2021-2030) ($MN)
  • Table 8 Global Agmatine Market Outlook, By Health & Beauty Stores (2021-2030) ($MN)
  • Table 9 Global Agmatine Market Outlook, By Third-party Online Channels (2021-2030) ($MN)
  • Table 10 Global Agmatine Market Outlook, By Other Sales Channels (2021-2030) ($MN)
  • Table 11 Global Agmatine Market Outlook, By Application (2021-2030) ($MN)
  • Table 12 Global Agmatine Market Outlook, By Supplements & Neutraceuticals (2021-2030) ($MN)
  • Table 13 Global Agmatine Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 14 Global Agmatine Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 15 North America Agmatine Market Outlook, By Country (2021-2030) ($MN)
  • Table 16 North America Agmatine Market Outlook, By Form (2021-2030) ($MN)
  • Table 17 North America Agmatine Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 18 North America Agmatine Market Outlook, By Powder (2021-2030) ($MN)
  • Table 19 North America Agmatine Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 20 North America Agmatine Market Outlook, By Specialty Stores (2021-2030) ($MN)
  • Table 21 North America Agmatine Market Outlook, By Drug Stores (2021-2030) ($MN)
  • Table 22 North America Agmatine Market Outlook, By Health & Beauty Stores (2021-2030) ($MN)
  • Table 23 North America Agmatine Market Outlook, By Third-party Online Channels (2021-2030) ($MN)
  • Table 24 North America Agmatine Market Outlook, By Other Sales Channels (2021-2030) ($MN)
  • Table 25 North America Agmatine Market Outlook, By Application (2021-2030) ($MN)
  • Table 26 North America Agmatine Market Outlook, By Supplements & Neutraceuticals (2021-2030) ($MN)
  • Table 27 North America Agmatine Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 28 North America Agmatine Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 29 Europe Agmatine Market Outlook, By Country (2021-2030) ($MN)
  • Table 30 Europe Agmatine Market Outlook, By Form (2021-2030) ($MN)
  • Table 31 Europe Agmatine Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 32 Europe Agmatine Market Outlook, By Powder (2021-2030) ($MN)
  • Table 33 Europe Agmatine Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 34 Europe Agmatine Market Outlook, By Specialty Stores (2021-2030) ($MN)
  • Table 35 Europe Agmatine Market Outlook, By Drug Stores (2021-2030) ($MN)
  • Table 36 Europe Agmatine Market Outlook, By Health & Beauty Stores (2021-2030) ($MN)
  • Table 37 Europe Agmatine Market Outlook, By Third-party Online Channels (2021-2030) ($MN)
  • Table 38 Europe Agmatine Market Outlook, By Other Sales Channels (2021-2030) ($MN)
  • Table 39 Europe Agmatine Market Outlook, By Application (2021-2030) ($MN)
  • Table 40 Europe Agmatine Market Outlook, By Supplements & Neutraceuticals (2021-2030) ($MN)
  • Table 41 Europe Agmatine Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 42 Europe Agmatine Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 43 Asia Pacific Agmatine Market Outlook, By Country (2021-2030) ($MN)
  • Table 44 Asia Pacific Agmatine Market Outlook, By Form (2021-2030) ($MN)
  • Table 45 Asia Pacific Agmatine Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 46 Asia Pacific Agmatine Market Outlook, By Powder (2021-2030) ($MN)
  • Table 47 Asia Pacific Agmatine Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 48 Asia Pacific Agmatine Market Outlook, By Specialty Stores (2021-2030) ($MN)
  • Table 49 Asia Pacific Agmatine Market Outlook, By Drug Stores (2021-2030) ($MN)
  • Table 50 Asia Pacific Agmatine Market Outlook, By Health & Beauty Stores (2021-2030) ($MN)
  • Table 51 Asia Pacific Agmatine Market Outlook, By Third-party Online Channels (2021-2030) ($MN)
  • Table 52 Asia Pacific Agmatine Market Outlook, By Other Sales Channels (2021-2030) ($MN)
  • Table 53 Asia Pacific Agmatine Market Outlook, By Application (2021-2030) ($MN)
  • Table 54 Asia Pacific Agmatine Market Outlook, By Supplements & Neutraceuticals (2021-2030) ($MN)
  • Table 55 Asia Pacific Agmatine Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 56 Asia Pacific Agmatine Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 57 South America Agmatine Market Outlook, By Country (2021-2030) ($MN)
  • Table 58 South America Agmatine Market Outlook, By Form (2021-2030) ($MN)
  • Table 59 South America Agmatine Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 60 South America Agmatine Market Outlook, By Powder (2021-2030) ($MN)
  • Table 61 South America Agmatine Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 62 South America Agmatine Market Outlook, By Specialty Stores (2021-2030) ($MN)
  • Table 63 South America Agmatine Market Outlook, By Drug Stores (2021-2030) ($MN)
  • Table 64 South America Agmatine Market Outlook, By Health & Beauty Stores (2021-2030) ($MN)
  • Table 65 South America Agmatine Market Outlook, By Third-party Online Channels (2021-2030) ($MN)
  • Table 66 South America Agmatine Market Outlook, By Other Sales Channels (2021-2030) ($MN)
  • Table 67 South America Agmatine Market Outlook, By Application (2021-2030) ($MN)
  • Table 68 South America Agmatine Market Outlook, By Supplements & Neutraceuticals (2021-2030) ($MN)
  • Table 69 South America Agmatine Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 70 South America Agmatine Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 71 Middle East & Africa Agmatine Market Outlook, By Country (2021-2030) ($MN)
  • Table 72 Middle East & Africa Agmatine Market Outlook, By Form (2021-2030) ($MN)
  • Table 73 Middle East & Africa Agmatine Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 74 Middle East & Africa Agmatine Market Outlook, By Powder (2021-2030) ($MN)
  • Table 75 Middle East & Africa Agmatine Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 76 Middle East & Africa Agmatine Market Outlook, By Specialty Stores (2021-2030) ($MN)
  • Table 77 Middle East & Africa Agmatine Market Outlook, By Drug Stores (2021-2030) ($MN)
  • Table 78 Middle East & Africa Agmatine Market Outlook, By Health & Beauty Stores (2021-2030) ($MN)
  • Table 79 Middle East & Africa Agmatine Market Outlook, By Third-party Online Channels (2021-2030) ($MN)
  • Table 80 Middle East & Africa Agmatine Market Outlook, By Other Sales Channels (2021-2030) ($MN)
  • Table 81 Middle East & Africa Agmatine Market Outlook, By Application (2021-2030) ($MN)
  • Table 82 Middle East & Africa Agmatine Market Outlook, By Supplements & Neutraceuticals (2021-2030) ($MN)
  • Table 83 Middle East & Africa Agmatine Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 84 Middle East & Africa Agmatine Market Outlook, By Other Applications (2021-2030) ($MN)